This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirandola, P.
Right arrow Articles by Di Luca, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirandola, P.
Right arrow Articles by Di Luca, D.

 Previous Article  |  Next Article 

J Virol, May 1998, p. 3837-3844, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Temporal Mapping of Transcripts in Herpesvirus 6 Variants

Prisco Mirandola, Paola Menegazzi, Stefania Merighi, Tullia Ravaioli, Enzo Cassai, and Dario Di Luca*

Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, Università di Ferrara, Ferrara, Italy

Received 22 December 1997/Accepted 30 January 1998

To define the molecular features characteristic of the early stages of infection of lymphocytes with human herpesvirus 6 (HHV-6) variant A or B, we studied the temporal regulation of expression of selected sets of viral genes. Thus, U42, U94, U89-U90, U73, and U39 are alpha  genes since their transcripts (i) were made in the presence of inhibitors of protein synthesis and (ii) were detected 3 h after infection of untreated cells. U41, U53, U31, and U19 are beta  genes since their expression is inhibited by cycloheximide but not by phosphonoacetate, an inhibitor of DNA synthesis. U100 is a gamma  gene since its spliced transcript encoding the structural glycoprotein gp82/105 was first detected 16 h after infection of untreated cells but could not be detected in cells treated with phosphonoacetate. HHV-6 variants differ in the transcription patterns of their genes. U16-U17 originates a splice transcript and is regulated as alpha  in HHV-6B and as beta  in HHV-6A. U91 generates two transcripts, amplified as 476- and 374-bp PCR fragments. The 476-bp fragment is alpha  in HHV-6A-infected cells but beta  in HHV-6B-infected cells. Conversely, the 374-bp fragment is beta  in HHV-6A-infected cells and alpha  in HHV-6B-infected cells. Furthermore, the spliced product of U18-U19-U20 (526 bp) is beta  in HHV-6A-infected cells, but only a partially spliced form (1.9 kb) was detected at late stages of infection in HHV-6B. HHV-6 transcription was also studied in nonproductive lymphoid cells, and the same transcription pattern detected during lytic infection was observed. Also, HHV-6 variants maintain the differences in U91, U16-17, and U18-U19-U20. We conclude that, as expected from the sequencing data, gene expression is generally similar in HHV-6 variants. However, transcription of selected genes in HHV-6A and HHV-6B differs with respect to temporal regulation and splicing pattern. Furthermore, the identification of viral functions expressed during the different stages of lytic replication suggests that reverse transcription-PCR for HHV-6 genes is a useful diagnostic approach to differentiate between latent and productive HHV-6 infection.

* Corresponding author. Mailing address: Sezione di Microbiologia, Dipartimento di Medicina Sperimentale e Diagnostica, Università di Ferrara, Via Borsari 46, 44100 Ferrara, Italy. Phone: (39) 532 291408. Fax: (39) 532 247618. E-mail: dil{at}dns.unife.it.

J Virol, May 1998, p. 3837-3844, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Comar, M, D'Agaro, P, Campello, C, Poli, A, Breinholt, J P III, Towbin, J A, Vatta, M (2009). Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J. Clin. Pathol. 62: 80-83 [Abstract] [Full Text]  
  • Kofod-Olsen, E., Ross-Hansen, K., Mikkelsen, J. G., Hollsberg, P. (2008). Human herpesvirus 6B U19 protein is a PML-regulated transcriptional activator that localizes to nuclear foci in a PML-independent manner. J. Gen. Virol. 89: 106-116 [Abstract] [Full Text]  
  • Alvarez-Lafuente, R., de las Heras, V., Garcia-Montojo, M., Bartolome, M., Arroyo, R. (2007). Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult Scler 13: 578-583 [Abstract]  
  • Comar, M., D'Agaro, P., Horejsh, D., Galvan, M., Fiorentini, S., Andolina, M., Caruso, A., Di Luca, D., Campello, C. (2005). Long-Lasting CD3+ T-Cell Deficiency after Cord Blood Stem Cell Transplantation in a Human Herpesvirus 6-Infected Child. J. Clin. Microbiol. 43: 2002-2003 [Abstract] [Full Text]  
  • De Bolle, L., Naesens, L., De Clercq, E. (2005). Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy. Clin. Microbiol. Rev. 18: 217-245 [Abstract] [Full Text]  
  • Alvarez-Lafuente, R., De las Heras, V., Bartolome, M., Picazo, J. J., Arroyo, R. (2004). Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection. Arch Neurol 61: 1523-1527 [Abstract] [Full Text]  
  • Rotola, A, Merlotti, I, Caniatti, L, Caselli, E, Granieri, E, Tola, M R, Di Luca, D, Cassai, E (2004). Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler 10: 348-354 [Abstract]  
  • Dockrell, D.H. (2003). Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol 52: 5-18 [Abstract] [Full Text]  
  • Stanton, R., Fox, J. D., Caswell, R., Sherratt, E., Wilkinson, G. W. G. (2002). Analysis of the human herpesvirus-6 immediate-early 1 protein. J. Gen. Virol. 83: 2811-2820 [Abstract] [Full Text]  
  • Oster, B., Hollsberg, P. (2002). Viral Gene Expression Patterns in Human Herpesvirus 6B-Infected T Cells. J. Virol. 76: 7578-7586 [Abstract] [Full Text]  
  • Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., Yamanishi, K. (2002). Identification of Human Herpesvirus 6 Latency-Associated Transcripts. J. Virol. 76: 4145-4151 [Abstract] [Full Text]  
  • Van den Bosch, G., Locatelli, G., Geerts, L., Faga, G., Ieven, M., Goossens, H., Bottiger, D., Oberg, B., Lusso, P., Berneman, Z. N. (2001). Development of Reverse Transcriptase PCR Assays for Detection of Active Human Herpesvirus 6 Infection. J. Clin. Microbiol. 39: 2308-2310 [Abstract] [Full Text]  
  • Flebbe-Rehwaldt, L. M., Wood, C., Chandran, B. (2000). Characterization of Transcripts Expressed from Human Herpesvirus 6A Strain GS Immediate-Early Region B U16-U17 Open Reading Frames. J. Virol. 74: 11040-11054 [Abstract] [Full Text]  
  • Mori, Y., Dhepakson, P., Shimamoto, T., Ueda, K., Gomi, Y., Tani, H., Matsuura, Y., Yamanishi, K. (2000). Expression of Human Herpesvirus 6B rep within Infected Cells and Binding of Its Gene Product to the TATA-Binding Protein In Vitro and In Vivo. J. Virol. 74: 6096-6104 [Abstract] [Full Text]  
  • Norton, R. A., Caserta, M. T., Hall, C. B., Schnabel, K., Hocknell, P., Dewhurst, S. (1999). Detection of Human Herpesvirus 6 by Reverse Transcription-PCR. J. Clin. Microbiol. 37: 3672-3675 [Abstract] [Full Text]  
  • Rotola, A., Cassai, E., Tola, M. R., Granieri, E., Di Luca, D. (1999). Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 67: 529-531 [Abstract] [Full Text]  
  • Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., Pellett, P. E. (1999). Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A. J. Virol. 73: 8040-8052 [Abstract] [Full Text]  
  • Isegawa, Y., Mukai, T., Nakano, K., Kagawa, M., Chen, J., Mori, Y., Sunagawa, T., Kawanishi, K., Sashihara, J., Hata, A., Zou, P., Kosuge, H., Yamanishi, K. (1999). Comparison of the Complete DNA Sequences of Human Herpesvirus 6 Variants A and B. J. Virol. 73: 8053-8063 [Abstract] [Full Text]  
  • Menegazzi, P., Galvan, M., Rotola, A., Ravaioli, T., Gonelli, A., Cassai, E., Di Luca, D. (1999). Temporal mapping of transcripts in human herpesvirus-7. J. Gen. Virol. 80: 2705-2712 [Abstract] [Full Text]  
  • Menotti, L., Mirandola, P., Locati, M., Campadelli-Fiume, G. (1999). Trafficking to the Plasma Membrane of the Seven-Transmembrane Protein Encoded by Human Herpesvirus 6 U51 Gene Involves a Cell-Specific Function Present in T Lymphocytes. J. Virol. 73: 325-333 [Abstract] [Full Text]  
  • Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., Di Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. USA 95: 13911-13916 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»